Stigma, defined as social devaluation based on negative stereotypes toward a particular population, is prevalent within health care and is a common phenomenon in disorders of gut‐brain interaction (DGBI). Characteristically, DGBI including functional dyspepsia (FD) lack a structural etiology to explain symptoms, have high psychiatric co‐morbidity, and respond to neuromodulators traditionally used to treat psychopathology. As a result, these disorders are frequently and wrongly presumed to be psychiatric and carry a great deal of stigma. Stigma has profound adverse consequences for patients, including emotional distress, medication non‐adherence, barriers to accessing care, and increased symptoms. The basis for stigma dates back to the 17th Century concept of mind‐body dualism. Patients and health care providers need to understand the factors that promote stigma and methods to ameliorate it. In this minireview, we address the data presented in Yan et al.'s (Neurogastroenterol Motil, 2020, e13956). We offer concrete solutions for clinicians to mitigate the impact of stigma to optimize treatment adherence and clinical outcomes for patients with DGBI.

中文翻译：

---

将污名化为治疗 DGBI 的障碍：临床医生的经验教训

污名，定义为基于对特定人群的负面刻板印象的社会贬值，在医疗保健中普遍存在，并且是肠脑相互作用障碍 (DGBI) 中的常见现象。特征性地，包括功能性消化不良 (FD) 在内的 DGBI 缺乏解释症状的结构性病因，具有较高的精神共病率，并且对传统上用于治疗精神病理学的神经调节剂有反应。因此，这些疾病经常被错误地假定为精神疾病，并带有大量的耻辱感。污名对患者有深远的不利影响，包括情绪困扰、药物不依从性、获得护理的障碍和症状增加。污名的基础可以追溯到 17 世纪的身心二元论概念。患者和医疗保健提供者需要了解导致污名化的因素以及改善污名化的方法。在这篇小型综述中，我们讨论了 Yan 等人 (Neurogastroenterol Motil, 2020, e13956) 中提供的数据。我们为临床医生提供具体的解决方案，以减轻耻辱感的影响，从而优化 DGBI 患者的治疗依从性和临床结果。